Chimerism
With chimerism determination, the percentage of donor and / or patient cells in blood or bone marrow is determined after allogeneic stem cell transplantation. Usually material is transplanted from one donor. However, transplants are also carried out in which material is transplanted from two donors. By determination of DNA polymorphisms that are specific for the patient and comparing them with those of the donors, the percentage of donor cells can be determined.
Contactperson
dr. A. Gerrits (Coördinator)Frequency
1 rounds of 3 samplesNumber of participants
9Price
Participation
€ 378.00
Details
Only institutes that participate in HOVON/SAKK clinical trials (eg HOVON132) can register for these quality assessments.
Supported analytes
| Percentage cellen |
Methodelijst Chimerism
| Percentage cellen | Consensus methodegroep |
|---|---|
| Chimerisme qPCR | Overall |
| Chimerisme VNTR PCR | Overall |
| Overig | Overall |
Analyzer
| Analyzer | Manufacturer |
|---|---|
| iCycler | Bio-Rad |
| GeneExpert | Cepheid |
| ABI Prism 7000 | Life Technologies |
| ABI Prism 7500 | Life Technologies |
| ABI Prism 7700 | Life Technologies |
| ABI Prism 7900 | Life Technologies |
| Overige | Overigen |
| Rotor Gene | Qiagen |
| Roche LightCycler 1.0 | Roche Diagnostics |
| Roche LightCycler 1.2 | Roche Diagnostics |
| Roche LightCycler 2.0 | Roche Diagnostics |
| Roche LightCycler 480 | Roche Diagnostics |
Questions about this scheme?
Use the form below to send us a message.
"*" indicates required fields